P71: Toward Treatment of Post-Traumatic Spinal Cord Injury: Differentiation of Oligodendrocytes from Adipose Stem Cells
Authors
Abstract:
This article doesn't have abstract
similar resources
P75: Toward Treatment of Post-Traumatic Spinal Cord Injury: Differentiation of Oligodendrocytes from Bone Marrow Stem Cells
لطفاً به چکیده انگلیسی مراجعه شود.
full textp75: toward treatment of post-traumatic spinal cord injury: differentiation of oligodendrocytes from bone marrow stem cells
traumatic central nervous system injuries lead to a severe and permanent neurological deficit. oligodendrocytes (olcs) are vulnerable to damage in a variety of neurologic diseases. although no effective therapeutic option is currently available, recent other studies have shown that cell therapeutic strategies hold promise to enhance functional recovery after injury. the aim of this study is to ...
full textP68: Combined Treatment of Spinal Cord Injury Using Transplantation of Motoneurons Derived Adipose Stem Cells and Adipose Mesenchymal Stem Cells Transfected with GDNF Following Valproic Acid Treatment
لطفاً به چکیده انگلیسی مراجعه شود.
full textP24: Neural Stem/Progenitor Cells Treatment for Spinal Cord Injury
لطفاً به چکیده انگلیسی مراجعه شود.
full textP8: Perspective of Nanotechnology and Stem Cells for Treatment of Spinal Cord Injury
لطفاً به چکیده انگلیسی مراجعه شود.
full textPOST-TRAUMATIC CHRONIC SPINAL CORD INJURY: ASSESSMENT WITH MRI
The initial experience concerning the use of magnetic resonance imaging in 94 patients who had sustained chronic cord injury showed its specific advantages over traditional imaging modalities. A variety of 84 cord abnormalities were identified including myelomalacia in 47%, cord cysts in 37%, focal atrophy in 11 % and cord transection in 5%. Canal stenosis was seen in twenty-five patients, ...
full textMy Resources
Journal title
volume 2 issue 4
pages 121- 121
publication date 2014-12
By following a journal you will be notified via email when a new issue of this journal is published.
No Keywords
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023